RPK Biopharma is committed to providing the highest quality standardized medicinal cannabis products, serving as a trusted resource for patients in need. Boasting the largest outdoor cultivation area in the northern hemisphere, spanning 650,000 m², RPK utilizes both indoor and outdoor growing methods to ensure year-round supply and cost-efficient production. Recognized as a Project of National Interest (PIN) by the Portuguese government, the brand emphasizes innovation through its international flagship R&D center, dedicated to customer-focused product development.

Led by a highly skilled team with extensive backgrounds in pharmaceuticals and fast-moving consumer goods (FMCGs), including seasoned professionals like Pauric Duffy, Founder and CEO, and CFO Pedro Viegas, RPK harnesses a wealth of knowledge in science, technology, operations, and finance. With expert cultivation management by Lead Grower Ben Jackson, the company emphasizes EU-GMP compliance in its production processes. RPK Biopharma is strategically positioned to advance the medicinal cannabis industry in Portugal and beyond, meeting the needs of patients while fostering sustainable growth.